```

[Federal Register Volume 87, Number 57 (Thursday, March 24, 2022)]
[Notices]
[Page 16750]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-06226]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Meeting of the Tick-Borne Disease Working Group

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As required by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the Tick-Borne Disease Working Group (TBDWG) will hold a virtual 
meeting. The meeting will be open to the public. For this meeting, the 
TBDWG will be discussing and voting on recommendations for the 2022 
TBDWG Report to the HHS Secretary and Congress. Most of the 
recommendations the TBDWG will consider are from the reports of five 
TBDWG subcommittees, which were created to examine critical topic areas 
related to tick-borne diseases. The 2022 report will address a wide 
range of topics related to tick-borne diseases, such as, surveillance, 
prevention, diagnosis, diagnostics, and treatment; identify advances 
made in research, as well as overlap and gaps in tick-borne disease 
research; and provide recommendations regarding any appropriate changes 
or improvements to such activities and research.

DATES: The meeting will be held online via webcast on April 27, 2022-
April 28, 2022 from approximately 9:00 a.m. to 5:00 p.m. ET (times are 
tentative and subject to change) each day. The confirmed times and 
agenda items for the meeting will be posted on the TBDWG web page 
https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2022-04-27/index.html when this information becomes available.

FOR FURTHER INFORMATION CONTACT: James Berger, Designated Federal 
Officer for the TBDWG; Office of Infectious Disease and HIV/AIDS 
Policy, Office of the Assistant Secretary for Health, Department of 
Health and Human Services, Mary E. Switzer Building, 330 C Street SW, 
Suite L600, Washington, DC 20024. Email: [email protected]. 
Phone: 202-795-7608.

SUPPLEMENTARY INFORMATION: Registration information can be found on the 
meeting website at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2022-04-27/index.html when it becomes 
available. The public will have an opportunity to present their views 
to the TBDWG orally during the meeting's public comment session or by 
submitting a written public comment. Comments should be pertinent to 
the meeting discussion. Persons who wish to provide verbal or written 
public comment should review instructions at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2022-04-27/index.html and 
respond by midnight April 15, 2022 ET. Verbal comments will be limited 
to three minutes each to accommodate as many speakers as possible 
during the 30 minute session. Written public comments will be 
accessible to the public on the TBDWG web page prior to the meeting.
    Background and Authority: The Tick-Borne Disease Working Group was 
established on August 10, 2017, in accordance with Section 2062 of the 
21st Century Cures Act, and the Federal Advisory Committee Act, 5 
U.S.C. App., as amended, to provide expertise and review federal 
efforts related to all tick-borne diseases, to help ensure interagency 
coordination and minimize overlap, and to examine research priorities. 
The TBDWG is required to submit a report to the HHS Secretary and 
Congress on their findings and any recommendations for the federal 
response to tick-borne disease every two years.

    Dated: March 14, 2022.
James J. Berger,
Designated Federal Officer, Tick-Borne Disease Working Group, Office of 
Infectious Disease and HIV/AIDS Policy.
[FR Doc. 2022-06226 Filed 3-23-22; 8:45 am]
BILLING CODE 4150-28-P
```